© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 14, 2020
Gopa Iyer, MD, discusses treatment-related adverse events (TRAEs) with erdafitinib (Balversa) in urothelial cancer.
April 03, 2020
Gopa Iyer, MD, discusses the challenges faced with identifying an optimal screening methodology to select patients with bladder cancer for FGFR inhibitor therapy.
March 20, 2020
Gopa Iyer, MD, discusses investigational FGFR inhibitors in metastatic urothelial carcinoma.